ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 268 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $773,021 | -8.8% | 29,743 | -10.8% | 0.00% | 0.0% |
Q1 2024 | $847,166 | -5.2% | 33,353 | +14.2% | 0.00% | 0.0% |
Q4 2023 | $893,918 | +13.9% | 29,213 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $784,953 | -24.4% | 29,213 | +0.4% | 0.00% | 0.0% |
Q2 2023 | $1,037,813 | +22.5% | 29,103 | -12.7% | 0.00% | 0.0% |
Q1 2023 | $847,166 | -37.4% | 33,353 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $1,352,798 | +14.9% | 33,353 | -6.3% | 0.00% | 0.0% |
Q3 2022 | $1,177,000 | -6.1% | 35,613 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,254,000 | -23.4% | 35,613 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $1,638,000 | -35.6% | 35,613 | -7.1% | 0.00% | -40.0% |
Q4 2021 | $2,542,000 | +4.9% | 38,343 | -1.2% | 0.01% | 0.0% |
Q3 2021 | $2,424,000 | -24.6% | 38,821 | 0.0% | 0.01% | -16.7% |
Q2 2021 | $3,215,000 | +26.8% | 38,821 | +1.6% | 0.01% | +20.0% |
Q1 2021 | $2,535,000 | -22.8% | 38,222 | -10.7% | 0.01% | -28.6% |
Q4 2020 | $3,284,000 | +76.5% | 42,802 | -1.0% | 0.01% | +75.0% |
Q3 2020 | $1,861,000 | +1.7% | 43,222 | +2.0% | 0.00% | -20.0% |
Q2 2020 | $1,830,000 | +50.1% | 42,372 | 0.0% | 0.01% | +25.0% |
Q1 2020 | $1,219,000 | -64.6% | 42,372 | -22.0% | 0.00% | -50.0% |
Q4 2019 | $3,444,000 | +150.1% | 54,298 | +11.1% | 0.01% | +100.0% |
Q3 2019 | $1,377,000 | +23.6% | 48,868 | +16.3% | 0.00% | +33.3% |
Q2 2019 | $1,114,000 | +57.6% | 42,032 | +9.0% | 0.00% | +50.0% |
Q1 2019 | $707,000 | +47.6% | 38,552 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $479,000 | -28.6% | 38,552 | +10.1% | 0.00% | -50.0% |
Q3 2018 | $671,000 | +49.4% | 35,010 | +6.0% | 0.00% | +100.0% |
Q2 2018 | $449,000 | +944.2% | 33,040 | +43.6% | 0.00% | – |
Q1 2017 | $43,000 | +19.4% | 23,004 | 0.0% | 0.00% | – |
Q4 2016 | $36,000 | -78.7% | 23,004 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $169,000 | +38.5% | 23,004 | 0.0% | 0.00% | – |
Q2 2016 | $122,000 | – | 23,004 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |